The Role of RUNX1 in NF1-Related Tumors and Blood Disorders

Youjin Na, Gang Huang, Jianqiang Wu

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder. NF1 patients are predisposed to formation of several type solid tumors as well as to juvenile myelomonocytic leukemia. Loss of NF1 results in dysregulation of MAPK, PI3K and other signaling cascades, to promote cell proliferation and to inhibit cell apoptosis. The RUNX1 gene is associated with stem cell function in many tissues, and plays a key role in the fate of stem cells. Aberrant RUNX1 expression leads to context-dependent tumor development, in which RUNX1 may serve as a tumor suppressor or an oncogene in specific tissue contexts. The co-occurrence of mutation of NF1 and RUNX1 is detected rarely in several cancers and signaling downstream of RAS-MAPK can alter RUNX1 function. Whether aberrant RUNX1 expression contributes to NF1-related tumorigenesis is not fully understood. This review focuses on the role of RUNX1 in NF1-related tumors and blood disorders, and in sporadic cancers.

Original languageEnglish (US)
Pages (from-to)153-159
Number of pages7
JournalMolecules and Cells
Volume43
Issue number2
DOIs
StatePublished - Feb 29 2020
Externally publishedYes

Keywords

  • cancer
  • mutation
  • neurofibromatosis type 1
  • RUNX1
  • tumor driver

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'The Role of RUNX1 in NF1-Related Tumors and Blood Disorders'. Together they form a unique fingerprint.

Cite this